Kairos Pharma, Ltd.'s total assets for Q3 2024 were $5.00M, an increase of 385.83% from the previous quarter. KAPA total liabilities were $1.67M for the fiscal quarter, a -12.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.